HIV, HCV and HBV: A Review of Parallels and Differences

Area of Science:

• Virology
• Infectious Diseases
• Public Health

Background:

• Significant advancements in antiviral therapies and prevention strategies for HIV, HBV, and HCV have been achieved.
• WHO global strategies support effective disease control for these three viral infections.
• The current lack of widely available vaccines for HIV and HCV hinders global elimination efforts.

Purpose of the Study:

• To compare and contrast HIV, HBV, and HCV, focusing on virologic and therapeutic aspects.
• To discuss the future prospects for controlling and potentially eliminating HBV.
• To assess the feasibility of eliminating these blood-borne viruses as public health issues.

Main Methods:

• Review of current scientific literature on HIV, HBV, and HCV.
• Analysis of virologic characteristics and therapeutic interventions for each virus.
• Evaluation of existing prevention strategies and vaccine availability.

Main Results:

• Highly effective antiviral agents and prevention methods are available for HIV, HBV, and HCV.
• Effective disease control is feasible for all three viruses according to WHO guidelines.
• A significant gap exists in vaccine availability, with only HBV having a widely implemented vaccine.

Conclusions:

• While control is achievable, global elimination of HIV, HBV, and HCV requires further development, particularly effective vaccines.
• HBV elimination prospects are more favorable due to vaccine availability, but challenges remain.
• A comparative approach highlights the distinct and shared hurdles in eradicating these major blood-borne viral infections.